Ceftaroline Fosamil Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Ceftaroline fosamil is a novel broad-spectrum cephalosporin approved by the EMA in 2012 for the treatment of adults with complicated skin and soft-tissue infections (cSSTIs) and community-acquired pneumonia (CAP) [18].Ceftaroline Fosamil Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceftaroline Fosamil Nitroso Impurity 2 CAS NO:NA chemically represented as (Z)-2-(2-(Ethoxyimino)-2-(5-(phosphonoamino)-1,2,4-thiadiazol-3-yl)acetamido)-2-(5-((4-(1-methylpyridin-1-ium-4-yl)thiazol-2-yl)thio)-3-nitroso-3,6-dihydro-2H-1,3-thiazin-2-yl)acetate . Synchemia is the leading manufacturing and exporter of Ceftaroline Fosamil Nitroso Impurity 2 . We supply Ceftaroline Fosamil Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143923 |
| CAS No | NA |
| Mol.F. | C5H13N3O2 |
| Mol.Wt. | 147.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143924 |
| CAS No | 65504-34-9 |
| Mol.F. | C6H13N3O |
| Mol.Wt. | 143.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143925 |
| CAS No | NA |
| Mol.F. | C10H19N3O |
| Mol.Wt. | 197.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143926 |
| CAS No | 2680529-63-7 |
| Mol.F. | C3H9N3O |
| Mol.Wt. | 103.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143927 |
| CAS No | 13256-15-0 |
| Mol.F. | C7H13N3O3 |
| Mol.Wt. | 187.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143928 |
| CAS No | 95732-53-9 |
| Mol.F. | C6H14N2O2 |
| Mol.Wt. | 146.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143929 |
| CAS No | 51938-16-0 |
| Mol.F. | C5H12N2O2 |
| Mol.Wt. | 132.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143930 |
| CAS No | 3121845-17-5 |
| Mol.F. | C9H12N2O4S |
| Mol.Wt. | 244.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143931 |
| CAS No | 1007-19-8 |
| Mol.F. | C7H7ClN2O |
| Mol.Wt. | 170.6 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143932 |
| CAS No | 819-35-2 |
| Mol.F. | C3H5F3N2O |
| Mol.Wt. | 142.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143933 |
| CAS No | NA |
| Mol.F. | C9H12N2O |
| Mol.Wt. | 164.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143934 |
| CAS No | 18907-82-9 |
| Mol.F. | C4H7N3O2 |
| Mol.Wt. | 129.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143935 |
| CAS No | 124485-93-4 |
| Mol.F. | C9H12N2O2 |
| Mol.Wt. | 180.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143936 |
| CAS No | NA |
| Mol.F. | C11H25N3O3Si |
| Mol.Wt. | 275.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143937 |
| CAS No | NA |
| Mol.F. | C7H13N3O |
| Mol.Wt. | 155.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143938 |
| CAS No | NA |
| Mol.F. | C7H12N4O2 |
| Mol.Wt. | 184.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |